article thumbnail

How the XR2 System Reduced Dispensing Errors by 92% for Summa Health

Omnicell

XR2 offered two key advantages – flexibility to support multiple distribution models including centralized, decentralized, or hybrid, and the ability to store and dispense many different form factors in their native manufacturer packaging. One of the most exciting features of XR2 is the dispensing accuracy.

article thumbnail

FDA tackles opioid crisis with OTC Narcan approval

Pharmaceutical Technology

The overdose death rate in the US increased more than 250% from 1999 to 2019, as per a Canada-US joint white paper on substance use and harms. According to Emergent , the delay is due to manufacturing changes that will need to be made to support nonprescription packaging, and supply chain modifications.

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Meeting global demand for patient independence: SHL Medical expands production in Charleston, US

Pharmaceutical Technology

As a vertically integrated company, SHL Medical prides itself on being an end-to-end partner, offering in-house capabilities at every stage – from design, development and production to final assembly, labelling and packaging. Download the white paper ‘Charleston, USA: A life sciences hub’ here.

article thumbnail

Module Type Package: Turning Visionary Concepts into Reality

ISPE

Module Type Package: Turning Visionary Concepts into Reality. Module Type Package: Turning Visionary Concepts into Reality. The Module Type Package (MTP) approach designates each module with a digital description, enabling flexible module connection and orchestration. Download White Paper. Trudy Patterson.

article thumbnail

The Digital Validation Handbook Your Guide to Faster, More Accurate Validation

ISPE

Documentation has experienced the same incredible advancements and that has significant impacts on industries that are dependent on it, such as the life sciences industry, consumer packaged goods manufacturers, and businesses involved in other highly regulated fields. Download White Paper To download this white paper, complete the form below.

article thumbnail

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

10 Diagnostics and biologics also heavily utilise carbon-based materials as constituting building blocks, processing aids, single-use reactors, or packaging materials. EFPIA White Paper on Circular Economy, June 2020. Org Process Res Dev 2020, 24, 10, 1996–2003. European Federation of Pharmaceutical Industries and Associations.

article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

4 , 5 Additionally, reducing shipping limitations—such as packaging, storage, and transportation durations—helps speed up patient access in certain instances while ensuring there is no negative impact to the product’s critical quality attributes (CQAs). These new operating models can help enable and accelerate the efforts of Pharma 4.0™